![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1780322
¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2021-2031³â) : ¼¼°è ¹× Áö¿ª Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® ¸®Æ÷Æ® - Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°Wearable EEG Devices Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, and Geography |
¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð´Â 2024³â 3¾ï 9,617¸¸ ´Þ·¯¿¡¼ 2031³â¿¡´Â 6¾ï 9,551¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2031³â ÃßÁ¤ CAGRÀº 8.7%ÀÔ´Ï´Ù.
Áö¿ªº°·Î ¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, Áß³²¹Ì·Î ±¸ºÐµË´Ï´Ù. 2024³â¿¡´Â À¯·´ÀÌ ½ÃÀå¿¡¼ Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼´Â ÀÎ½Ä Áõ°¡, Á÷Àå³» ½ºÆ®·¹½º Áõ°¡, ÆÒµ¥¹Í ÀÌÈÄ Á¤½Å°Ç°¿¡ ¹ÌÄ¡´Â ¿µÇâ Áõ°¡, Á¤½Å°Ç°¿¡ ´ëÇÑ ³íÀÇ Áõ°¡ µîÀ¸·Î ÀÎÇØ Á¤½Å°Ç°°ú ÀÎÁöÀû À£ºùÀ» ¿ì¼±½ÃÇÏ´Â ¹æÇâÀ¸·ÎÀÇ ¹®ÈÀû, »çȸÀû ÀüȯÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. °³ÀεéÀÌ Á¤½ÅÀû À£ºùÀ» ¸ð´ÏÅ͸µÇÏ°í °ÈÇϱâ À§ÇØ º¸´Ù Àû±ØÀûÀÌ°í µ¥ÀÌÅͺ£À̽ºÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Ãß±¸ÇÔ¿¡ µû¶ó ¿þ¾î·¯ºí EEG ÀåÄ¡°¡ ½Ç¿ëÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î Åø·Î µîÀåÇϰí ÀÖ½À´Ï´Ù. Emotiv, NeuroSky¿Í °°Àº °³¹ß»çµéÀº ÀÌ·¯ÇÑ Çõ½ÅÀ» Ȱ¿ëÇÏ¿© ÇコÄɾî, °ÔÀÓ, Á¤½Å°Ç°À» À§ÇÑ µð¹ÙÀ̽º¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù. µ¶ÀÏ, ÇÁ¶û½º, ¿µ±¹À» Áß½ÉÀ¸·Î ÇÑ À¯·´ÀÇ ÅºÅºÇÑ ÇコÄɾî ÀÎÇÁ¶ó´Â °·ÂÇÑ R&D »ýŰè¿Í ÀÇ·á½Ã¼³¿¡¼ÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ» ÅëÇØ ½ÃÀå ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.
EUÀÇ Çõ½Å ·¹ÀÌ´õ¿Í °°Àº Á¤ºÎ ±¸»óÀº È޸պ극ÀÎ ÇÁ·ÎÁ§Æ®(HBP)¿¡¼ ºñ·ÔµÈ Çõ½Å¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. 2013-2023³â±îÁö ÁøÇàµÈ HBP´Â À¯·´¿¬ÇÕ ÁýÇàÀ§¿øÈ¸ÀÇ FET Ç÷¡±×½Ê ÇÁ·ÎÁ§Æ®À̸ç, ÁÖ¿ä ¼º°ú Áß Çϳª°¡ EBRAINS ¿¬±¸ ÀÎÇÁ¶óÀÔ´Ï´Ù. EBRAINS´Â ¸¹Àº Çõ½ÅÀ» Áö¿øÇϰųª ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖÀ¸¸ç, ±× Áß ÀϺδ ½ºÇÉ¿ÀÇÁ(spin-off)·Î »ó¾÷Àû Á¦°øÀ¸·Î ³ª¾Æ°¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤½Å°Ç° ¹× ÀÎÁö ´É·Â¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ±³À°, ½ºÆ÷Ã÷ ¹× ±âŸ ºñÀÇ·á ºÐ¾ß¿¡¼ ¿þ¾î·¯ºí EEG¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. EUÀÇ ÀÇ·á±â±â ±ÔÁ¦(MDR)¿Í °°Àº ±ÔÁ¦Àû Áö¿øÀº Á¦Ç°ÀÇ ¾ÈÀü¼ºÀ» º¸ÀåÇÏ°í ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ ³ôÀÔ´Ï´Ù. ÇÏÀÌÅ×Å© ±â¾÷°ú ¿¬±¸±â°ü°£ÀÇ Á¦ÈÞ¿Í °°Àº Àü·«Àû ÆÄÆ®³Ê½Ê°ú ¿ø°ÝÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ÀÌ·¯ÇÑ À庮À» ¿ÏÈÇϰí, µ¶Àϰú ¿µ±¹ÀÌ Ã·´Ü ±â¼ú ¹× ÇコÄɾî ÇÁ·¹ÀÓ¿öÅ©·Î ¼±µµÇϰí ÀÖ´Â °Íó·³ À¯·´À» ¼¼°è ¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀåÀÇ ÁÖ¿ä ÁÖ¿ä ±â¾÷À¸·Î ÀÚ¸®¸Å±èÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀå ºÐ¼®Àº ´ÙÀ½°ú °°Àº ºÎ¹®À» °í·ÁÇÏ¿© ¼öÇàµË´Ï´Ù. (Á¦Ç°,¿ëµµ)
¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ¼¼°è ½ÃÀåÀº Á¦Ç°º°·Î 32ä³Î EEG, 14ä³Î EEG, 5ä³Î EEG, ±âŸ·Î ±¸ºÐµË´Ï´Ù. 15-32ä³Î EEG ½Ã½ºÅÛÀº ±âº»ÀûÀÎ ³úÆÄ ¸ÅÇκÎÅÍ °í±Þ ³ú ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI), ¼ö¸é, ÀÎÁö ¼º´É, °¨Á¤ ó¸® µîÀÇ ºÐ¾ß ¿¬±¸¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¿ëµµ¸¦ Áö¿øÇÕ´Ï´Ù. 32ä³Î ¼³Á¤Àº ´õ ³ôÀº µ¥ÀÌÅÍ ÇØ»óµµ¸¦ Á¦°øÇÏÁö¸¸, 15ä³Î ½Ã½ºÅÛÀº ¸¹Àº ÀÌ¿ë »ç·Ê, ƯÈ÷ È޴뼺°ú ¿¹»ê Á¦¾àÀÌ Áß¿äÇÑ ¿ä¼ÒÀÎ °æ¿ì ¿©ÀüÈ÷ À¯È¿ÇÕ´Ï´Ù. 15-32ä³Î EEG ½Ã½ºÅÛÀº ÀÓ»ó ¹× ¿¬±¸ ȯ°æ¿¡¼ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÓ»óÀûÀ¸·Î´Â ¼ö¸éÀå¾Ö, ³úÁ¾¾ç, ³úÁ¹Áß µî ½Å°æÇÐÀû »óÅÂÀÇ Áø´Ü ¹× ¸ð´ÏÅ͸µÀ» Áö¿øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î 32 ä³Î ³úÆÄ ½Ã½ºÅÛÀº °íÇØ»óµµ ³ú Ȱµ¿ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© ÀÓ»óÀǰ¡ °£Áú ȯÀÚÀÇ ¹ßÀÛ ¿øÀÎÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. 19ä³Î ¼³Á¤¿¡¼ Àü±ØÀº µÎÇÇÀÇ ÀüµÎºÎ, Áß¾ÓºÎ, Á¤¼ö¸®, Èĵκθ¦ ¸ð´ÏÅ͸µÇϱâ À§ÇØ Àü·«ÀûÀ¸·Î ¹èÄ¡µÇ¾î °ø°£ ÇØ»óµµ¿Í ÀÛµ¿ È¿À²ÀÇ È¿°úÀûÀÎ ÀýÃæÁ¡À» Á¦°øÇÕ´Ï´Ù. ÀÌ ±¸¼ºÀº ½Å·Ú¼º°ú ½Ç¿ë¼ºÀ¸·Î ÀÎÇØ ¼ö¸é ¿¬±¸ ¹× °£Áú Áø´ÜÀ» Æ÷ÇÔÇÑ ÀÓ»ó ÇöÀå¿¡¼ ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ ½Å°æÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀÌ ¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É°úÀÇ ÅëÇÕÀº ÇâÈÄ ¼ö³â°£ »õ·Î¿î ¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀå µ¿ÇâÀ» °¡Á®¿Ã °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ¼¼°è ½ÃÀå(¿ëµµº°)Àº °Ç°/À£´Ï½º, ÈÞ¸Õ-¸Ó½Å ÀûÀÀÇü »óÈ£ÀÛ¿ë, ÀÚµ¿Â÷, Ç×°ø, »ê¾÷, ±âŸ·Î ±¸ºÐµË´Ï´Ù. ¿þ¾î·¯ºí ³úÆÄ ÀåÄ¡´Â ´Ù¸¥ »ý¸®Àû ÁöÇ¥¿Í ÇÔ²² ³ú Ȱµ¿À» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ´É·ÂÀ¸·Î ÀÎÇØ °Ç° ¹× À£´Ï½º ºÐ¾ß¿¡¼ °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ¼ö¸é ÃÖÀûÈ, ÀÎÁö ´É·Â, Á¤½Å°Ç° µîÀÇ ºÐ¾ß¿¡¼ °³ÀÎÈµÈ °Ç° °ü·Ã ÀλçÀÌÆ®¿Í ¸ÂÃãÇü °³ÀÔÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¼ÒÇüÀÇ ºñħ½ÀÀû ÀåÄ¡´Â ½Å°æ ½ÅÈ£ÀÇ Áö¼ÓÀûÀÎ ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» ÅëÇØ °£Áú, ¼ö¸éÀå¾Ö, ºÒ¾È ¹× ¿ì¿ïÁõ°ú °°Àº Á¤½Å°Ç° ¹®Á¦¿Í °°Àº ½Å°æÇÐÀû »óŸ¦ Á¶±â¿¡ ¹ß°ßÇϰí È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ ¿þ¾î·¯ºí EEG ±â¼úÀº ¹ÙÀÌ¿À Çǵå¹é ¹× °³ÀÎÈµÈ ½Å°æÄ¡·á ¼Ö·ç¼ÇÀ» ÅëÇØ ÀÎÁö ´É·Â ÃÖÀûÈ, ¸í»ó ¿¬½À °È, ¼ö¸éÀÇ Áú Çâ»óÀ» Áö¿øÇÔÀ¸·Î½á °Ç° ÁõÁøÀ» ÃËÁøÇÕ´Ï´Ù. 2025³â 3¿ù, AI¸¦ Ȱ¿ëÇÑ ³ú °Ç° ±â¼úÀÇ ¼±µÎÁÖÀÚÀÎ ¿¡ÇÇÅÚÀº ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÌ REMI ¹«¼± EEG ½Ã½ºÅÛ¿¡ ´ëÇÑ 510(k) Çã°¡¸¦ Ãß°¡ ½ÂÀÎÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. À̹ø ½ÂÀÎÀ¸·Î 1¼¼ ÀÌ»óÀÇ ¿µÀ¯¾Æ ¹× ¼Ò¾Æ·Î ÀûÀÀÁõÀÌ È®´ëµÇ¾î REMI°¡ ¸Å¿ì Ãë¾àÇÑ È¯ÀÚ±ºÀÇ ½Å°æ ¸ð´ÏÅ͸µ¿¡ º¯È¸¦ °¡Á®¿Ã ¼ö ÀÖ´Â °¡´É¼ºÀ» º¸¿©ÁÖ¾ú½À´Ï´Ù.
BrainBit, ANT Neuro, Brain Products GmbH, Electrical Geodesics, Inc.(Koninklijke Philips N.V.), EMOTIV, g.tec medical engineering GmbH, Neuroelectrics, Cadwell Industries, Inc. µîÀÌ ¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀå¿¡¼ »ç¾÷À» ¿î¿µÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.
¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀå ¿¹ÃøÀº ÁÖ¿ä ±â¾÷ °£Ç๰, Çùȸ µ¥ÀÌÅÍ, µ¥ÀÌÅͺ£À̽º µî ´Ù¾çÇÑ 2Â÷ ¹× 1Â÷ Á¶»ç °á°ú¸¦ ±â¹ÝÀ¸·Î ÃßÁ¤µÇ¾ú½À´Ï´Ù. ¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀåÀÇ ¼ºÀå°ú °ü·ÃµÈ ÁúÀû, ¾çÀû Á¤º¸¸¦ ¾ò±â À§ÇØ, »ç³» ¹× ¿ÜºÎÀÇ ´Ù¾çÇÑ Ãâó¸¦ ÅëÇØ Á¾ÇÕÀûÀÎ 2Â÷ Á¶»ç¸¦ ½Ç½ÃÇß½À´Ï´Ù. ÀÌ °úÁ¤À» ÅëÇØ ¸ðµç ½ÃÀå ºÎ¹®¿¡ ´ëÇÑ ½ÃÀå °³¿ä¿Í ¿¹ÃøÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¥ÀÌÅ͸¦ °ËÁõÇÏ°í ºÐ¼®Àû ÀλçÀÌÆ®¸¦ ¾ò±â À§ÇØ ¾÷°è °ü°èÀÚ¸¦ ´ë»óÀ¸·Î ¿©·¯ Â÷·ÊÀÇ 1Â÷ ÀÎÅͺ並 ÁøÇàÇß½À´Ï´Ù. ÀÌ °úÁ¤¿¡´Â ºÎ»çÀå, ½ÃÀå °³¹ß ¸Å´ÏÀú, ½ÃÀå ÀÎÅÚ¸®Àü½º ¸Å´ÏÀú, ±¹³» ¿µ¾÷ ¸Å´ÏÀú µî ¾÷°è Àü¹®°¡¿Í ¿þ¾î·¯ºí EEG µð¹ÙÀ̽º ½ÃÀåÀ» Àü¹®À¸·Î ÇÏ´Â Æò°¡ Àü¹®°¡, ¸®¼Ä¡ ¾Ö³Î¸®½ºÆ®, KOL(Key Opinion Leader) µî ¿ÜºÎ ÄÁ¼³ÅÏÆ®µéÀÌ Âü¿©ÇÕ´Ï´Ù. Âü¿©ÇÕ´Ï´Ù.
The wearable EEG devices market size is expected to reach US$ 695.51 million by 2031 from 396.17 million in 2024, at an estimated CAGR of 8.7% from 2025 to 2031.
By Geography the Wearable EEG Devices market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. In 2024, Europe held a significant share in the market. Europe has witnessed a significant cultural and societal shift toward prioritizing mental health and cognitive wellness owing to increasing awareness, growing workplace stress, rising mental health impacts post-pandemic, and the surging normalization of mental health discourse. As individuals seek more proactive, data-driven approaches to monitor and enhance their mental well-being, wearable EEG devices have emerged as practical and accessible tools. Companies such as Emotiv and NeuroSky are leveraging these innovations to develop devices for healthcare, gaming, and mental wellness. Europe's robust healthcare infrastructure, particularly in Germany, France, and the UK, supports market growth through strong R&D ecosystems and widespread adoption in medical facilities.
Government initiatives, such as the EU's Innovation Radar, highlight innovations stemming from the Human Brain Project (HBP). Running from 2013 to 2023, the HBP was a FET Flagship Project of the European Commission, with one of its key outcomes being the EBRAINS Research Infrastructure. EBRAINS supports or makes available many of the innovations, and a number of them have made the step to commercial offerings as spinoffs. Additionally, growing consumer awareness of mental health and cognitive performance drives demand for wearable EEGs in education, sports, and other non-medical sectors. Regulatory support, such as the EU's Medical Device Regulation (MDR), ensures product safety, boosting consumer trust. Strategic partnerships, such as those between tech firms and research institutes, and increasing investments in telehealth solutions are expected to mitigate these barriers, positioning Europe as a key player in the global wearable EEG market, with Germany and the UK leading due to their advanced technological and healthcare frameworks.
The Wearable EEG Devices market analysis has been carried out by considering the following segments: Product and Application.
The Global Wearable EEG Devices Market, by Product, is segmented into 32-Channel EEG, 14-Channel EEG, 5-Channel EEG, and Others. EEG systems in the range of 15-32 channels support a wide range of applications, from basic brainwave mapping to advanced brain-computer interfaces (BCIs) and research in areas such as sleep, cognitive performance, and emotional processing. While 32-channel setups provide higher data resolution, 15-channel systems remain effective for many use cases, particularly when portability and budget constraints are key factors. EEG systems within 15 to 32 channels are widely utilized across clinical and research environments. Clinically, they support the diagnosis and monitoring of neurological conditions such as sleep disorders, brain tumors, stroke, and others. For instance, a 32-channel EEG system offers high-resolution brain activity data, enabling clinicians to identify seizure origins in epilepsy patients. In a 19-channel setup, electrodes are strategically placed to monitor the frontal, central, parietal, and occipital areas of the scalp, offering an effective compromise between spatial resolution and operational efficiency. This configuration is widely adopted in clinical settings, including sleep research and epilepsy diagnostics, due to its reliability and practicality.
Moreover, factor such as growing prevalence of neurological disorders and increasing geriatric population propel the wearable EEG devices market growth. Also, integration with artificial intelligence is expected to bring new wearable EEG devices market trends in the coming years.
The Global Wearable EEG Devices Market, by Application, is segmented into Health and Wellness, Human Machine Adaptive Interaction, Automotive, Aviation, Industrial, and Others. Wearable EEG devices are gaining traction in the health and wellness sector for their capability to monitor brain activity alongside other physiological metrics. This enables the delivery of personalized health insights and targeted interventions in areas such as sleep optimization, cognitive performance, and mental well-being. These compact, non-invasive devices allow for continuous real-time monitoring of neural signals, enabling early detection and effective management of neurological conditions such as epilepsy, sleep disorders, and mental health challenges, including anxiety and depression. Additionally, wearable EEG technology promotes wellness by assisting users in optimizing cognitive performance, enhancing meditation practices, and improving sleep quality through biofeedback and personalized Neurotherapy solutions. In March 2025, Epitel, a frontrunner in AI-powered brain health technologies, announced that the US Food and Drug Administration (FDA) had granted an additional 510(k) clearance for the REMI Wireless EEG System. This clearance expands the indications for use to include infants and children aged one year and older, highlighting REMI's potential to transform neurological monitoring in this highly vulnerable patient group.
BrainBit, ANT Neuro, Brain Products GmbH, Electrical Geodesics, Inc. (Koninklijke Philips N.V.), EMOTIV, g.tec medical engineering GmbH, Neuroelectrics, Cadwell Industries, Inc., Wearable Sensing, and NeuroSky are among the key players profiled in the Wearable EEG Devices market report.
The Wearable EEG Devices market forecast is estimated on the basis of various secondary and primary research findings such as key company publications, association data, and databases. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the Wearable EEG Devices market growth. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the Wearable EEG Devices market.